Do you want to read an article? Please log in or register.
Clinical Correlations of Brain Lesion Location in Multiple Sclerosis: Voxel-Based Analysis of a Large Clinical Trial Dataset
Aging and Cognitive FunctionsMultiple Sclerosis
Related content
Multiple Sclerosis
Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis
Brain.
Elliott C, Belachew S, Wolinsky JS, Hauser SL, Kappos L, Barkhof F, Bernasconi C, Fecker J, Model F, Wei W, Arnold DL
doi: 10.1093/brain/awz212.
Multiple Sclerosis
A comparison of brain magnetic resonance imaging lesions in multiple sclerosis by race with reference to disability progression
J Neuroinflammation.
Nakamura Y, Gaetano L, Matsushita T, Anna A, Sprenger T, Radue EW, Wuerfel J, Bauer L, Amann M, Shinoda K, Isobe N, Yamasaki R, Saida T, Kappos L, Kira JI
doi: 10.1186/s12974-018-1295-1.
Multiple Sclerosis
Assessment of a home-based standing frame programme in people with progressive multiple sclerosis (SUMS): a pragmatic, multi-centre, randomised, controlled trial and cost-effectiveness analysis
Lancet Neurol.
Freeman J, Hendrie W, Jarrett L, Hawton A, Barton A, Dennett R, Jones B, Zajicek J, Creanor S
doi: 10.1016/S1474-4422(19)30190-5.
RECOMMENDED
Multiple Sclerosis
Central Slab versus Whole Brain to Measure Brain Atrophy in Multiple Sclerosis
Eur Neurol.
Ruberte E, Sinnecker T, Amann M, Gaetano L, Naegelin Y, Penner IK, Kuhle J, Derfuss T, Kappos L, Granziera C, Wuerfel J, Yaldizli Ö
doi: 10.1159/000495798.
Multiple Sclerosis
Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis
N Engl J Med.
Metz LM, Li DKB, Traboulsee AL, Duquette P, Eliasziw M, Cerchiaro G1, Greenfield J, Riddehough A, Yeung M, Kremenchutzky M, Vorobeychik G, Freedman MS, Bhan V, Blevins G, Marriott JJ, Grand'Maison F, Lee L, Thibault M, Hill MD, Yong VW; Minocycline in MS Study Team
doi: 10.1056/NEJMoa1608889.
Migraine and HeadacheMultiple Sclerosis
Safety and efficacy of dual-lead thalamic deep brain stimulation for patients with treatment-refractory multiple sclerosis tremor: a single-centre, randomised, single-blind, pilot trial
Lancet Neurol.
Oliveria SF, Rodriguez RL, Bowers D, Kantor D, Hilliard JD, Monari EH, Scott BM, Okun MS, Foote KD
doi: 10.1016/
Multiple Sclerosis
Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis
Brain
Barro C, Benkert P, Disanto G, Tsagkas C, Amann M, Naegelin Y, Leppert D, Gobbi C, Granziera C, Yaldizli Ö, Michalak Z, Wuerfel J, Kappos L, Parmar K, Kuhle J
doi: 10.1093/brain/awy154.
RECOMMENDED
Multiple Sclerosis
Early clinical markers of aggressive multiple sclerosis
★ 2
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
Brain.
Malpas CB, Manouchehrinia A, Sharmin S, Roos I, Horakova D, Havrdova EK, Trojano M, Izquierdo G, Eichau S, Bergamaschi R, Sola P, Ferraro D, Lugaresi A, Prat A, Girard M, Duquette P, Grammond P, Grand'Maison F, Ozakbas S, Van Pesch V, Granella F, Hupperts R, Pucci E, Boz C, Sidhom Y, Gouider R, Spitaleri D, Soysal A, Petersen T, Verheul F, Karabudak R, Turkoglu R, Ramo-Tello C, Terzi M, Cristiano E, Slee M, McCombe P, Macdonell R, Fragoso Y, Olascoaga J, Altintas A, Olsson T, Butzkueven H, Hillert J, Kalincik T
doi: 10.1093/brain/awaa081.
Multiple Sclerosis
Tablet App Based Dexterity Training in Multiple Sclerosis (TAD-MS): Research Protocol of a Randomized Controlled Trial
Front Neurol.
van Beek JJW, van Wegen EEH, Bol CD, Rietberg MB, Kamm CP, Vanbellingen T
doi: 10.3389/fneur.2019.00061.